The Oncology Institute, Inc.TOINASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank57
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-27.79M
↓ 14% vs avg
Percentile
P57
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
$-24.42M
Historical baseline
PeriodValueYoY Change
TTM$-27.79M+8.4%
2024$-30.33M+25.8%
2023$-40.88M+39.2%
2022$-67.28M-88.3%
2021$-35.73M-5108.0%
2020$-686000.00-128.5%
2019$2.41M-51.3%
2018$4.95M-